Time-pattern of adverse outcomes after an infection-triggered acute heart failure decompensation and the influence of early antibiotic administration and hospitalisation: results of the PAPRICA-3 study

Objective To investigate whether patients with an acute heart failure (AHF) episode triggered by infection present different outcomes compared to patients with no trigger and the effects of early antibiotic administration (EAA) and hospitalisation. Methods Two groups were made according to the AHF t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical research in cardiology 2020, Vol.109 (1), p.34-45
Hauptverfasser: Miró, Òscar, Takagi, Koji, Gayat, Étienne, Gil, Víctor, Llorens, Pere, Martín-Sánchez, Francisco J., Jacob, Javier, Herrero-Puente, Pablo, Escoda, Rosa, Pilar López-Díez, María, Valero, Amparo, Fuentes, Marta, Garrido, José M., Salvo, Eva, Rizzi, Miguel A., Aguirre, Alfons, Travería Bécquer, Lissete, Domínguez-Rodríguez, Alberto, Padrosa, Joan, Martínez, Gemma, Arrigo, Mattia, Freund, Yonathan, Mebazaa, Alexandre
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective To investigate whether patients with an acute heart failure (AHF) episode triggered by infection present different outcomes compared to patients with no trigger and the effects of early antibiotic administration (EAA) and hospitalisation. Methods Two groups were made according to the AHF trigger: infection (G1) or none identified (G2). The primary outcome was 13-week (91-days) all-cause mortality, and secondary outcomes were 13-week post-discharge mortality, readmission or combined endpoint. Comparisons are presented as unadjusted and adjusted (MEESSI risk score) hazard ratios (uHR/aHR) for G1 compared to G2 patients, also estimated by weeks. Stratified analysis by EAA (provided/not provided) and patient disposition (discharged/hospitalised) was performed. Results We included 6727 patients (G1 = 3973; G2 = 2754). The 13-week mortality uHR was 1.11 (0.99–1.25; p  = 0.06; with significant increases in the first 3 weeks), and the aHR was 0.91 (0.81–1.02; p  = 0.11). There were no differences in unadjusted secondary post-discharge outcomes; however, G1 outcomes significantly improved after adjustment: aHR 0.83 (0.71–0.96; p  = 0.01) for mortality, 0.92 (0.84–0.99; p  = 0.04) for readmission, and 0.92 (0.85–0.99; p  = 0.04) for the combined endpoint. We found a differentiated effect of hospitalisation ( p  
ISSN:1861-0684
1861-0692
DOI:10.1007/s00392-019-01481-3